Literature DB >> 10198187

Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes.

S C Armstrong1, M Delacey, C E Ganote.   

Abstract

Small heat shock proteins (hsp) have been implicated in mediation of classic preconditioning in the rabbit, Hsp27 is a terminal substrate of the p38 MAPK cascade. One and 2D gel electrophoresis and immunoblotting of cell fractions was used to determine p38 MAPK and hsp27 phosphorylation levels, respectively, during in vitro ischemia in control, calyculin A (Cal A)-treated (protein phosphatase inhibitor), SB203580-treated (p38MAPK inhibitor) and preconditioned (IPC) isolated adult rabbit cardiomyocytes. The dual phosphorylation of p38 MAPK was increased by early ischemia (30-60 min), after which there was a loss of total cytosolic p38 MAPK. The ischemic increase of p38 MAPK dual phosphorylation was enhanced by IPC. Cal A strongly activated dual phosphorylation of p38 MAPK in oxygenated cells and this was maintained into early ischemia, SB203580 inhibited the dual phosphorylation of p38 MAPK and attenuated the loss of total cytosolic p38 MAPK. In each protocol, ischemia translocated hsp27 from the cytosolic fraction to the cytoskeletal fraction at similar rates and extents, Hsp27 phosphorylation was quantitated as the fraction of diphosphorylated hsp27, based on IEF mobility shifts of hsp27 phosphorylation isoforms. In oxygenated control cells, cytosolic and cytoskeletal hsp27 was highly phosphorylated. After 90 min ischemia, cytoskeletal hsp27 was markedly dephosphorylated. Cal A slightly increased control cytoskeletal hsp27 phosphorylation. During ischemic incubation, Cal A blocked ischemic dephosphorylation, SB203580 accelerated ischemic hsp27 dephosphorylation and injury, IPC insignificantly decreased the initial rate of ischemic dephosphorylation of hsp27, but not the extent of dephosphorylation in later ischemia. Phosphorylation is regulated by both kinase and phosphatase activities. IPC protection was not correlated with a significant increase in cytosolic or cytoskeletal hsp27 phosphorylation levels during prolonged (> 60-90 min) ischemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198187     DOI: 10.1006/jmcc.1998.0891

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  15 in total

1.  Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.

Authors:  A Punn; J W Mockridge; S Farooqui; M S Marber; R J Heads
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

2.  p38 Mitogen-activated protein kinase mediates a negative inotropic effect in cardiac myocytes.

Authors:  Pu Liao; Shi-Qiang Wang; Su Wang; Ming Zheng; Meizi Zheng; Sheng-Jun Zhang; Heping Cheng; Yibin Wang; Rui-Ping Xiao
Journal:  Circ Res       Date:  2002-02-08       Impact factor: 17.367

3.  An ischemic beta-dystroglycan (betaDG) degradation product: correlation with irreversible injury in adult rabbit cardiomyocytes.

Authors:  Stephen C Armstrong; Carole A Latham; Charles E Ganote
Journal:  Mol Cell Biochem       Date:  2003-01       Impact factor: 3.396

Review 4.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

5.  Effect of p38 MAP kinases on contractility and ischemic injury in intact heart.

Authors:  H R Cross; M Li; B G Petrich; E Murphy; Y Wang; Charles Steenbergen
Journal:  Acta Physiol Hung       Date:  2009-09

Review 6.  HSP27: mechanisms of cellular protection against neuronal injury.

Authors:  R A Stetler; Y Gao; A P Signore; G Cao; J Chen
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

7.  MAPKAPK-2 modulates p38-MAPK localization and small heat shock protein phosphorylation but does not mediate the injury associated with p38-MAPK activation during myocardial ischemia.

Authors:  Diana A Gorog; Rita I Jabr; Masaya Tanno; Negin Sarafraz; James E Clark; Simon G Fisher; Xou Bin Cao; Mohamed Bellahcene; Kushal Dighe; Alamgir M N Kabir; Roy A Quinlan; Kanefusa Kato; Matthias Gaestel; Michael S Marber; Richard J Heads
Journal:  Cell Stress Chaperones       Date:  2009-02-13       Impact factor: 3.667

8.  Pharmacologically activated migration of aortic endothelial cells is mediated through p38 SAPK.

Authors:  László Dénes; Andrea Jednákovits; Judit Hargitai; Zoltán Pénzes; András Balla; László Tálosi; Péter Krajcsi; Péter Csermely
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

Review 9.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury.

Authors:  Elizabeth Murphy; Charles Steenbergen
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

10.  Effect of remote ischemic preconditioning on phosphorylated protein signaling in children undergoing tetralogy of Fallot repair: a randomized controlled trial.

Authors:  Salvatore Pepe; Norman Y Liaw; Michele Hepponstall; Freya L Sheeran; Matthew S Yong; Yves d'Udekem; Michael M Cheung; Igor E Konstantinov
Journal:  J Am Heart Assoc       Date:  2013-05-10       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.